Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 2,332.40
+27.95 (1.21%)
At close: Mar 5, 2026
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
10.89M INR
Profits / Employee
1.93M INR
Market Cap
1.07T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | 18,573 | 271 | 1.48% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Torrent Pharmaceuticals | 17,059 |
| Jubilant Pharmova | 5,547 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| CORONA Remedies | 4,500 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
Lupin News
- 6 days ago - Lupin Goa facility clears US FDA inspection with VAI classification - Business Upturn
- 9 days ago - Lupin receives USFDA approval for Brivaracetam Oral Solution, launches in US market - Business Upturn
- 17 days ago - Lupin signs licensing and supply agreement with Spektus Pharma to commercialise DeslaFlex in Canada - Business Upturn
- 20 days ago - Lupin Ltd (BOM:500257) Q3 2026 Earnings Call Highlights: Record Growth and Strategic Milestones - GuruFocus
- 20 days ago - Q3 2026 Lupin Ltd Earnings Call Transcript - GuruFocus
- 4 weeks ago - Lupin launches Topiramate Extended-Release Capsules in the US after FDA approval - Business Upturn
- 4 weeks ago - Lupin collaborates with TB Alliance to advance new treatment for Tuberculosis and other mycobacterial diseases - Business Upturn
- 6 weeks ago - Lupin shares in focus today as company sign license and supply agreement for Semaglutide across 23 countries - Business Upturn